243 related articles for article (PubMed ID: 36888998)
21. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
22. Editorial: Organoids, organs-on-chip, nanoparticles and
Mattei F; George JT; Jolly MK
Front Immunol; 2023; 14():1253551. PubMed ID: 37533861
[No Abstract] [Full Text] [Related]
23. Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine.
El Harane S; Zidi B; El Harane N; Krause KH; Matthes T; Preynat-Seauve O
Cells; 2023 Mar; 12(7):. PubMed ID: 37048073
[TBL] [Abstract][Full Text] [Related]
24. 3D Models for Ovarian Cancer.
Kast V; Loessner D
Adv Exp Med Biol; 2021; 1330():139-149. PubMed ID: 34339035
[TBL] [Abstract][Full Text] [Related]
25. [Advances in three-dimensional tumor models for colorectal cancer].
Wang CT; Zhou JL; Lin GL; Yin SY; Cong L; Zhang GN; An Y; Qiu XY
Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):464-470. PubMed ID: 37355464
[TBL] [Abstract][Full Text] [Related]
26. Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance.
Lamberti MJ; Rettel M; Krijgsveld J; Rivarola VA; Rumie Vittar NB
Cell Oncol (Dordr); 2019 Apr; 42(2):173-196. PubMed ID: 30756254
[TBL] [Abstract][Full Text] [Related]
27. Microfluidic organoids-on-a-chip: The future of human models.
Saorin G; Caligiuri I; Rizzolio F
Semin Cell Dev Biol; 2023 Jul; 144():41-54. PubMed ID: 36241560
[TBL] [Abstract][Full Text] [Related]
28. A 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance.
Reidy E; Leonard NA; Treacy O; Ryan AE
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435170
[TBL] [Abstract][Full Text] [Related]
29. Spheroids and organoids derived from colorectal cancer as tools for
Ahmad Zawawi SS; Salleh EA; Musa M
Explor Target Antitumor Ther; 2024; 5(2):409-431. PubMed ID: 38745769
[TBL] [Abstract][Full Text] [Related]
30. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids.
Ding L; Yang Y; Lu Q; Cao Z; Weygant N
Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398
[TBL] [Abstract][Full Text] [Related]
31. Microfluidic organ-on-chip system for multi-analyte monitoring of metabolites in 3D cell cultures.
Dornhof J; Kieninger J; Muralidharan H; Maurer J; Urban GA; Weltin A
Lab Chip; 2022 Jan; 22(2):225-239. PubMed ID: 34851349
[TBL] [Abstract][Full Text] [Related]
32. [3D Tumor organoid models produced by cellular capsules technology CCT].
Recher G; Mombereau A; Boyreau A; Nassoy P; Andrique L
Bull Cancer; 2022 Jan; 109(1):38-48. PubMed ID: 34996600
[TBL] [Abstract][Full Text] [Related]
33. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
Pyo DH; Hong HK; Lee WY; Cho YB
Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid.
Lee SW; Kwak HS; Kang MH; Park YY; Jeong GS
Sci Rep; 2018 Feb; 8(1):2365. PubMed ID: 29403007
[TBL] [Abstract][Full Text] [Related]
35. Clinical applications of 3D normal and breast cancer organoids: A review of concepts and methods.
Lewis SM; Callaway MK; Dos Santos CO
Exp Biol Med (Maywood); 2022 Dec; 247(24):2176-2183. PubMed ID: 36408534
[TBL] [Abstract][Full Text] [Related]
36. Impact of a Desmoplastic Tumor Microenvironment for Colon Cancer Drug Sensitivity: A Study with 3D Chimeric Tumor Spheroids.
Goudar VS; Koduri MP; Ta YN; Chen Y; Chu LA; Lu LS; Tseng FG
ACS Appl Mater Interfaces; 2021 Oct; 13(41):48478-48491. PubMed ID: 34633791
[TBL] [Abstract][Full Text] [Related]
37. 3D modeling in cancer studies.
Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
[TBL] [Abstract][Full Text] [Related]
38. On-chip recapitulation of the tumor microenvironment: A decade of progress.
Giannitelli SM; Peluzzi V; Raniolo S; Roscilli G; Trombetta M; Mozetic P; Rainer A
Biomaterials; 2024 Apr; 306():122482. PubMed ID: 38301325
[TBL] [Abstract][Full Text] [Related]
39. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
Elife; 2020 Nov; 9():. PubMed ID: 33138918
[TBL] [Abstract][Full Text] [Related]
40. Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection.
Johnson KA; DeStefanis RA; Emmerich PB; Grogan PT; Kratz JD; Makkar SK; Clipson L; Deming DA
Curr Treat Options Oncol; 2020 Apr; 21(5):35. PubMed ID: 32328818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
